Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07935213

Seroprevalence and Risk Factors of H. Pylori Infection in Korea in 2023: Nationwide Multicenter Prospective Study

Conditions: HELICOBACTER PYLORI INFECTIONS, Colon Adenomas

Sex: All
Ages: 19 Years – N/A
Healthy volunteers: Yes
Enrollment: 19680
Sponsor: Seoul National University Bundang Hospital

Location: Seoul National University Bundang Hospital Seongnam-si Gyeonggi-do

Summary

Helicobacter pylori Infection in South Korea: Seroprevalence, Risk Factors, and Association with Colorectal Adenoma

Eligibility Criteria

Inclusion Criteria: * Individuals undergoing routine health screening at 10 healthcare centers in South Korea between July 2023 and December 2024. The study included participants who underwent Helicobacter pylori serologic testing and gastrointestinal endoscopic examinations. Exclusion Criteria: * Individuals without colonoscopy or esophagogastroduodenoscopy records. * History of colectomy. * Inflammatory bowel disease. * Gastric cancer or a history of gastrectomy for gastric cancer.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07935213). StuddyBuddy aggregates publicly available trial information.